>
Epstein Client List BOMBSHELL, Musk's 'America Party' & Tucker's Iran Interview | PB
The Hidden Cost of Union Power: Rich Contracts and Layoffs Down the Road
Do They Deserve It? Mexico Is Collapsing As The US Deports Illegals Back Home
Copper Soars To Record High As Trump Unleashes 50% Tariff
Insulator Becomes Conducting Semiconductor And Could Make Superelastic Silicone Solar Panels
Slate Truck's Under $20,000 Price Tag Just Became A Political Casualty
Wisdom Teeth Contain Unique Stem Cell That Can Form Cartilage, Neurons, and Heart Tissue
Hay fever breakthrough: 'Molecular shield' blocks allergy trigger at the site
AI Getting Better at Medical Diagnosis
Tesla Starting Integration of XAI Grok With Cars in Week or So
Bifacial Solar Panels: Everything You NEED to Know Before You Buy
INVASION of the TOXIC FOOD DYES:
Let's Test a Mr Robot Attack on the New Thunderbird for Mobile
Facial Recognition - Another Expanding Wolf in Sheep's Clothing Technology
There are currently over 100 COVID-19 vaccines going through trials, most of which focus on the use of antibodies, a powerful immune-system weapon.
A new paper published in Nature from Swiss, French, and American scientists identified an antibody taken from a patient infected with the SARS (severe acute respiratory syndrome) virus during the outbreak in 2003 that seems to neutralize COVID-19's infection potential.
Antibodies are produced by the immune-system in response to foreign material in the body. 25 antibodies were identified as potentially competent in detecting the COVID-19 virus and binding to its spike protein, the docking mechanism that allows the virus to infiltrate our cells. Eight of these were found to be able to bind both to free viruses and already infected cells.
One candidate, named S309 was shown to have particularly strong neutralizing activity against COVID-19, and by solving the crystal structure of S309, the authors demonstrated how the antibody binds to the viral spike protein while working in combination with another, less potent, antibody that targets a different site on the spike.
This synergistic activity could enhance neutralization while reducing the chance of resistant mutations emerging, the authors suggest.
RELATED: Optimistic COVID-19 Statistics For Vast Numbers of US States Reported For May
The Killer T-Cell
Another weapon in the immune-system's arsenal are killer T-cells. These compounds help us fight some viruses, but throughout the COVID-19 pandemic their role as potentially helpful or benign has been unclear.
Two studies, according to Science, have found that the killer T-cells of COVID-19 positive patients have the potential to both identify and destroy the now famous virus. Moreover, the studies revealed that some people who have never been exposed to COVID-19 also harbor these T-cells—most likely because they were infected with another form of coronavirus in the past.